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Summary
Active tissue thromboplastin can be separated into an inactive protein frac-
tion and a lipid fraction. Recombination of these moieties results in an active
thromboplastin. Most complete regeneration of the thromboplastin activity
was obtained by a modified solubilization-dialysis procedure using taurocholate
at pH 4.0.
The protein moiety combined with pure phospholipids produced no throm-
boplastin activity, except for phosphatidylethanolamine which produced only
low activity. Highly active preparations were obtained by relipidation of the
protein moiety with binary phospholipid mixtures. Mixtures most effective in
iestoring the thromboplastin activity were phosphatidylethanolamine/phospha-
tidylserine 65/35 (w/w), phosphatidylcholine/phosphatidylserine 57143 (w/w)
and phosphatidylcholine /phosphatidylglycerol 48 | 52 (w/w).
Mixtures of alkylamine and phospholipid combined with the thrombo-
plastin protein also regenerated the activity. Oleoylamine/phosphatidylserine
33167 (w/w) and stearoylamine/phosphatidylglycerol 15/85 (w/w) were found
to be optimum mixtures.
One characteristic feature for each optimum lipid mixture was an identical
electrophoretic mobility. This consistent observation demonstrates that n pdr:
ticular charge of the lipid moiety is a requirement for optimum exhibition of
the activity of the thromboplastin protein. .: ;
Lipids containing unsaturated fatty acids were found to be another require-
ment. Increased unsaturation in the fatty acids correlated with an increase in
the thromboplastin activity of the recombinant. Complete saturation resulted
in inactive preparations.
. fresent address and to whom reprint requests should be addressed: Gaubius Institute, Health
Research Organization TNO, Herenstraat 5d, Leiden. The Netherlands.
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Introduction
Lipids are important constituents of tissue thromboplastin preparations, as
originally observed by Wooldridge [1]. He injected tissue extracts of various
origins in animals and observed no lethal effect if the preparations were pre-
viously extracted with alcohol-ether. Mills [2] confirmed these findings with a
purified thromboplastin preparation from beef lung and was able to regain
most of the high clot-promoting activity by recombination of the less active
lipid fraction with the inactive protein fraction.
Continued investigations showed that two procedures are suitable for the
restoration of the clotting function starting with the lipid and protein fractions
of tissue thromboplastin. In the first method, the lipid fraction is dissolved in
an organic solvent such as pyridine [3], chloroform [4] or ethanol [5] and the
dry protein fraction is added. After mixing, the solvent is evaporated and the
residue suspended in saline or buffer. The second method consists of solubiliza-
tion of the lipids in a buffered aqueous medium containing sodium deoxy-
cholate, followed by the addition of protein. During dialysis against buffer, the
detergent is removed and recombination takes place. The degree of restoration
of thromboplastin activity is influenced by the pH and ionic strength of the
buffer [6].
Substitution of the natural lipid mixture by various single natural and syn-
thetic phospholipids was first performed by Kuhn and Klesse [7] to inves-
tigate the involvement of a specific phospholipid in the restoration of the
thromboplastin activity. The results of their recombination experiments and
those of some other investigations showed that natural phosphatidylethanol-
amines which contain both saturated and unsaturated fatty acids appear to be
the most effective f4,5,7,81, whereas phosphatidylethanolamines with only
saturated fatty acids are not [7,8]. Inactive preparations were obtained after
reassociation of the protein moiety with phosphatidylserine, phosphatidyl-
inositol, phosphatidic acid and synthetic phosphatidylcholines; the results
with biological species of phosphatidylcholine are not identical. Nevertheless,
definite conclusions about the lipid requirements of the protein moiety of
tissue thromboplastin can hardly be drawn.
In this communication, the pH dependence of the recombination is
described, using taurocholate instead of deoxycholate. Recombination of the
purified protein moiety of porcine lung thromboplastin with several defined
phospholipid mixtures and phospholipid/alkylamine mixtures revealed impor-
tant information about the lipid requirements of this clotting factor. An
abstract of this study has been published [9].
Materials and Methods
Porcine lung thromboplastin (TP) was prepared from fresh lungs by differ-
ential centrifugation according to the method of Chargaff et al. [10] with some
modifications [11].
Purified protein moiety of porcine lung thromboplastin was obtained after
delipidation of .the lyophilized thromboplastin with n-heptaneln-butanol 2/1
(v/v) followed by gel filtration of the solubilized protein fraction on Sephadex
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G-200 in the presence of 0.25% sodium deoxycholate 1121.
Phosphotipid mixture of porcine lung thromboplastin was isolated from the
n-heptaneln-butanol extract of the thromboplastin. The extract was evaporated
under reduced pressure and the residue was dissolved in chloroform. This solu-
tion was applied to a silicic acid column previously equilibrated with chloroform.
Neutral lipids were eluted with chloroform/methanol mixtures cont'aining 57o
and t\Vo (v/v) methanol. This was followed by the elution of the phospho-
lipids. For that pu{pose, the methanol concentration was gradually increased
from 75Vo to 60Vo (v/v). These fractions were combined and evaporated and the
residue was dissolved in n-pentane. Traces of silicic acid were removed by the
addition of \Vo (v/v) of water followed by centrifugation f.ot 20 min at 2000 X
g at room temperature. The supematant was evaporated and the phospholipid
mixture was dissolved in n-pentane, which had been dessicated over anhydrous
sodium carbonate, and stored under nitrogen at -20" C.
Phospholipid. suspension was prepared from the petroleum ether extract of
acetone-dried human brain tissue. The extract was evaporated under reduced
pressure and the lipids were dissolved in diethyl ether. This solution was added
dropwise to a stirred veronal-acetate buffer through which nitrogen was
bubbled. The suspension obtained was stored aL -20" C (11). This preparation
served as the lipid surface for the formation of the prothrombin activating com-
plex in the assay of thromboplastin activity.
Phosphatidtc acid was kindly supplied by Dr. J. de Gier of the Laboratory
of Biochemistry. It was prepared from egg yolk phosphatidylcholine by degra-
dation with phospholipase D, which had been extracted from savoy cabbage
according to Davidson and Long [13].
Phosphatidylcholine was isolated from egg yolk according to Singleton et al.
[14]" This was followed by chromatography on aluminium oxide using the
stepwise elution method of Renkonen t15] with an increased methanol
concentration (5O7o) to elute phosphatidylcholine. After evaporation under
reduced pressure, the phosphati<iylcholine fraction was dissolved in n-pentane.
Water (57.) (vlv) was added to moisten traces of aluminium oxide which were
sedimented subsequently by centrifugation at 2000 X g for 20 min. The super-
natant was evaporated and the phospholipid preparation dissolved in n-pentane
which had been dried over anhydrous sodium carbonate. The solution was
stored in ampoules at -20'C under nitrogen.
Degradation of the phosphatidylcholine preparation, in particular, could be
detected in an early stage from the electrophoretic mobility measurements. In
that case, the chromatography on aluminium oxide was repeated or a new
preparation was started
Phosphatidylethanolamine was purified from the crude egg yolk phospho-
lipids obtained by the method of Singleton et al. [14]. This preparation was
applied to a silicic acid column equilibrated with chloroform. Elution was per-
formed with chloroform/methanol mixtures with increasing methanol concen-
tration. Phosphatidylethanolamine was recovered at 75Vo methanol. This
preparation was further purified on DEAE-cellulose using "elution sequence
3" as described by Rouser et al. [16], resulting in a phosphatidyl-
ethanolamine preparation which showed one single spot on silica gel thin
layer chromatography. This preparation was dried under reduced pressure, dis-
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solved in dry n-pentane and stored in ampoules at -20"C under nitrogen.
Synthetic dipalmitoyl phosphatidylethanolamine and dioleoyl phosphatidyl-
ethanolamine were obtained as generous gifts from Dr. J.D. Billimoria, West-
minster School of Medicine, Biochemical Research Laboratory, London, Eng-
land.
Phosphatidylglycerol was prepared from egg yolk phosphatidylcholine
according to the method of Lennarz et al. [17]. This procedure was performed
by Dr. H.M. Verheij of the Laboratory of Biochemistry.
Phosphatidylserine was purified from porcine brain tissue using the method
of Sanders [18]. Hydrogenated phosphatidylserine was made from the natural
preparation by passing hydrogen through a solution of phosphatidylserine in
rz-heptane in the presence of activated palladium for 5 h at room temperature.
The hydrogenated phosphatidylserine was stored in chloroform at -20'C.
Recornbination of the purified protein moiety and phospholipid was per-
formed by the solubilization-dialysis procedure. An aliquot of the phospho-
lipid stock solution corresponding to 1.0 mg phospholipid was dried under
vacuum and sr:lubilized in 0.3 ml veronal/chloride buffer (1 0.015, pH 7.35)
containing sodium taurocholate (1,.37.). A protein preparation containing 0.7
mg protein was added and the volume was adjusted to 1.0 ml with buffer.
Removal of the taurocholate was achieved by dialysis for 65 to 70 h at 4"C
against 6 changes of buffer. Sodium acetatelacetic acid buffers (0.01 M) were
used during dialyzing from pH 3.0 to 6.0; in the pH region 6 to 8.5, sodium
5,5-diethyl-barbiturate (0.01 M) adjusted with hydrochloric acid was used.
For recombination with mixtures of phospholipids the constituent phos-
pholipids were mixed in the desired proportions in chloroform solution. After
evaporation of the solvent under vacuum, the residue was solubilized and
recombined with the protein as above.
Thromboplqstin actiuity of the recombinants was estimated by the two-
stage assay described earlier [11]. The first stage involved an incubation of
purified human factor VII with the sample in the presence of calcium chloride.
The degree of activation of factor VII was subsequently determined in a clot-
ting system consisting of artificially depleted factor VII reagent, the phos-
pholipid suspension and calcium chloride. The degree of activation was found
to be directly proportional to the thromboplastin activity of the sample.
The activity was calculated from the clotting time with the aid of a stan-
dard curve and it was expressed in percent activity with reference to an equal
amount of standard recombinant. The standard curve was plotted from the
clotting times of a series of dilutions of an arbitrarily chosen preparation ob-
tained by the recombination of the natural thromboplastin phospholipid mix-
ture with delipidated thromboplastin at pH 4.0. The rectilinear relationship
between the clotting time and 1/(lthromboplastin] + 1; also held for the
recombinant activity [12]. Phospholipids were inactive in this assay system,
indicating its specificity for tissue thromboplastin activity.
Prothrombinase formation. The capacity of the lipid of a recombinant to
function as the lipid surface in prothrombinase formation can be determined
by using Russell Viper Venom for rapid activation of factors X and V. This test
was performed in the presence of the phospholipid suspension in order to
determine whether there was a possible influence of the lipid of the recom-
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binant on the prothrombinase formation in the assay of thromboplastin activity.
A mixture of 0.1 ml factor VII reagent, 0.1 ml phospholipid suspension with
optimal concentration and 0.1 ml recombinant (diluted 1 to 3 with buffer) was
incubated for 30 s at 37'C. Thereafter, 0.1 ml Russell Viper Venom (0.1 mg/
100 ml) in 0.033 M calcium chloride was added and the clotting time deter-
mined.
In a number of samples of a defined expenment involving recombinants with
a parbicular combination of phospholipids, the sample with the shortest
clotting time, exhibiting optimal prothrombinase activity, was therefore taken
as 700%. Using dilutions of this recombinant in the test system resulted in clot-
ting times which showed a rectilinear gr?ph when plotted on double loga-
rithmic paper against the amount of the recombinant. Using this, the prothrom-
binase formation by other samples in the experiment can be expressed as a
percentage of the activity with regard to the optimal phospholipid suspension/
recombinant mixture.
Protein was estimated by the method of Lowry et al. [19].
Phosphorus was determined according to the procedure described by Rouser
e t  a l .  [20 ] .
Taurocholate was measured as the absorbance in 65% sulphuric acid at 320
nm.
' Electrophoretic mobility (tt) of phospholipid particles was measured with
the microelectrophoresis apparatus described by Bangham et al. (21). A 1.0 mg
amount of phospholipid was taken from the stock solution or from the stock
solutions in case of mixtures and the solvent was evaporated under vacuum.
The residue was suspended by hand-shaking in 5:0 ml veronal/chloride buffer
(/ 0.015, pH 7.35) with the addition of 1 or 2 glass beads. The mobility was
expressed as cm2 ' s-l ' V-r.
Results
Determination of pH optimum for recombination
The application of taurocholate fot "solubilization" of the lipid in the
recombination procedure for the lipid and protein moiety of thromboplastin
was found to be very suitable. It did not inactivate the protein and it could be
removed quite reasonably by dialysis (Table I). The dialysis time for removal
of the detergent from a recombinant was shorter than that for the phospholipid
alone. This is possibly the result of the competitive association of lipid and pro-
tein. In the succeeding recombination experiments, a dialysis time of 65 to 70
hours was employed in order to be sure that no residual taurocholate, which
could lead to false results concerning the lipid requirements of the protein,
was present.
Taurocholate has the advantage of being soluble over a wide pH range.
Therefore, we were able to demonstrate that recombination of the phospho-
lipid mixture of thromboplastin and its protein moiety produced the highest
clotting activity if the detergent was removed by dialysis at pH 4.0. This result
indicates that, for optimal restoration, the conditions must be favourable from
an electrostaiic point of view.
Mixing of a suspension of the phospholipid mixture and the protein moiety
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TABLE I
REMOVAL OF SODIUM TAUROCHOLATE FR,OM DIFFERENT SOLUTIONS BY DIALYSIS
AGAINST O.O1 M ACETATE BUFFER. pH 4.O.
Dialysis time
(h)
Sodium taurocholate removed (7o)
OnIy solvent Phospholipid
( lVo l
Phospholipid (LVo) + proteln (O.1Vo)
o
16
24
40
48
68
92
116
r40
o
95.2
I  ? .8
100
o
91 .0
95 .4
100
also produced a lipid'protein complex at pH 4.0, but this complex showed
no thromboplastin activity. This demonstrates that the solubilization-dialysis
procedure is essential to regain the thromboplastin activity.
Recombination of the protein moiety and phospholipids, alkylamines, or their
mi"xtures
Pure phospholipids were found to be rather ineffective in the restoration of
the thromboplastin activity of the protein moiety. Thus, the recombinants with
phosphatidic acid, phosphatidylcholine, phosphatidylglycerol and phosphati-
dylserine did not displa5z thromboplastin activity, in spite of the fact that
recombination had occurred. The recombinant with phosphatidylethanolamine
was active but the activity was rather low (10 to L57o) when compared with the
activity of the standard recombinant.
However, considerably higher activity of the recombinant was found if phos-
phatidylethanolamine was mixed with phosphatidylserine (Fig. 1). Especially
phosphatidylethanolamine/phosphatidylserine 65,35 (w/w) u/as very active. No
special differences in the extent of dispersion of the various recombinants were
observed by using the optical system of the microelectrophoresis apparatus.
Comparable results were obtained with mixtures of phosphatidylcholine and
phosphatidylserine (Fig. 1). The optimal activities of both types of mixtures
were rnarkedly higher than the activity obtained with the phospholipid mix-
ture of thromboplastin. By the addition of phosphatidylserine to the phospho-
lipid mixture, the activity of the recombinant could be increased and it was
optimum at227o phosphatidylserine (Fig. 1).
The data for the electrophoretic mobilities of the different phospholipids
and phospholipid mixtures in Fig. 1 showed that maximum activity always was
obtained at a particular charge of the lipid. Maximum activity coincided with
mixtures which had an electrophoretic mobility of -7.00, -7.t5 and -6'95 '
L0.a cm2 . s-t . V-t in 0.015 M veronal/chloride buffer, pH ?.35 (Fig. 1). Addi-
tional proof was obtained with mixtures of phosphatidylcholine and phos-
phatidylglycerol and phosphatidylglycerol and stearoylamine. The electro-
phoretic mobilities of phosphatidylcholine/phosphatidylglycerol 48152 (w/w)
o
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99.O
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Fig. 1. lnfluence of phospholipid composition upon the activity of the recombinant. Relipidation of
purified protein moiety of porcine lung thromboplastin with egg phosphatidylethanolamine/brain phos-
phatidvlserine mixtures (PE/PS), with egg phosphatidylcholine/brain phosphatidylserine mixtures (pC/pS)
or with the thromboplastin phospholipid mixture endched with brain phosphatidylserine (PLIPS) at pH
4.0. The thromboplastin activity of the recombinants is expressed in percent activity with refetence to
the same amount of recombinant containing the th-romboplastin phospholipid mixture, The electro-
phoretic mobilitv (p) of the phospholipid mixtures was measured in O.O15 M veronal/chloride buffer.
pH 7.35. The prothrombinase formation was measured as indicated in the text.
and phosphatidylglycerol/stearoylamine 85/1b (w/w) conesponding with
maximum act iv i t ies were -7.15 and -?.00.10-4 cm2.s- l  .  v- l ,  respect ively
lr2l.
Besides the influence of the surface charge of the lipid on the thrombo-
plastin activity of the recombinant, the variation in the degree of saturation of
the fatty acid chains was investigated in some mixtures. There was a marked
difference between the activity of recombinants with mixtures of dioleoyl
phosphatidylethanolamine and brain phosphatidylserine and those of dipal-
mitoyl phosphatidylethanolamine and hydrogenated brain phosphatidylserine.
In the preparations containing saturated fatty acids, no thromboplastin activity
could be elicited (Fig. 2). The importance of unsaturated chains was confirmed
by using mixtures of an alkylamine and phosphatidylserine with a more gradual
increase in degree of saturation (Fig. 2).
The observed curves representing the thromboplastin activity of the recom-
binants in Fig. 1 and 2 might be due, however, to selective binding of certain
phospholipid mixtures to the protein moiety. At the same time, the recom-
binant lipid mixture could have an effect on the prothrombinase formation in
the thromboplastin assay in spite of the addition of the phospholipid suspen-
sion. This would be expressed in the clotting times and consequently in the
thromboplastin activities of the recombinants. Control experiments were there-
fore performed on the recombinant preparations to verify the observed
phenomenon. The pH of the recombinant preparations was adjusted to ?.b to
evclude electrostatic interactions between the lipid and protein. The prepara-
tion was then subjected to centrifugation under different conditions. Deter-
mination of the protein content in the supernatant after centrifugation for 2 h
I
<  - 3
j-
!
9 - 4
' i
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F i g . 2 . I n f l u e n c e o f t h e d e g r e e o f s a t u r a t i o n o f t h e l i p i d m o i e t y o n t h e t h r o m b o p l a s t i n a c t i v i t y o f t h e
recombinant. Relipidation of purified 
proteln moi"iJ of thromboplastin with dioleovl 
phosphatidvl-
ethanolamine/blain phosphatidylserine mixtures 
(A), with dipalmitovl phosphatidvlethanolamine/hvdro-
gemtedbrainphosphatidylserinemixtureslr;,witholeoylamine/brainphosphatidylserinemixtures(o)'
withstearoylamine/-brainphosphatidylsednemixtures(r,)orwithsteuoylamine/hydrogemtedbrainphos-
phatidylserine mixtures (') at pH 4'O' Further details 
as in Fig' 1'
a t 3 ? 0 0 0 X g r e v e a l e d t h a t 9 5 t o 9 9 % o f t h e p r o t e i n w a s s e d i m e n t e d i n a l l
recombinants. A similar centrifugation after inciease 
in the density of the sus-
pensions to 1.0g nj an equal v;lume of 38Vo sucrose 
solution, followed by a
phosphorus assay of the supernatantt demonstrated 
that 95 to t00Vo of the
phospho l ip idwaspresent in t r repe l le t ,whe leasphospho l ip ida loned idnot
sediment. so, there was no selective binding of 
certain phospholipid mixtures
to the protein *oiutv;-i' all recombinants,Loth 
the phospholipid and the pro-
tein moieties were completely associated with each 
other'
The effect of the recombinant on the prothrombinase 
formation in the
assay of its thromboplastin activity was stuaied 
in a test system in which the
variable activation oi tu"to, X by mixtures of 
factor VII and the different
recombinants was substituted by a constant amount 
of Russell Viper venom'
Theseresu l tsshowedthat thec lo t t ingo f fac to rV l l reagent in thepresenceof
the phospholipid ,"Jp"".i." wasslighily affected 9y 
tl" type of recombinant
present (Fig. 1: pElps and pc/ps-r""oibinurrts1. Himination 
of the phospho-
lipid suspension from this test demonstratea inat 
the lipid moiety of par-
ticular recombinants did not adequately serve 
as the lipid surface of the pro-
thrombinase (Fig. 1: pl/ps recombinJnts). These 
observations demonstrate
that, in the assay oitt " 
tirromboptastin activity of the recombinants, the 
phos-
pholipid s.rsp"nsion ur-ort "o*il"t"ly 
accomplished its expected role in the
formation of the protrrro*ui" aciivating complex. 
Furbhermore' this proves the
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absolute necessity for the phospholipid suspension in the assay of thrombo-
plastin activity.
Discussion
Lipids play an important role in the action of several enzymes, among which
is tissue thromboplastin. Studies on the lipid requirements of these enzymes
have resulted in several procedures for recombining the lipids and the proteins.
One of these procedures consists of sotubilization of the lipid by a detergent,
addition of the protein and removal of the detergent by dialysis. This technique
was found to also be useful in the recombination of the lipid and protein
moiety of tissue thromboplastin [22]. However, the conditions for maximum
recombination were not described.
Nemerson [6] investigated the effect of a pH range of 7.2 to 9.2 on the
recornbination process, but he was not able to discover an optimum pH rlue to
the insolubility of the deoxycholic acid at lower pH values. He effected an
improvement of the relipidation by the addition of sodium chloride. This ob-
servation and the favourable effect of salts on the recombination of lipids and
protein in other studies suggest a neutralizing action of cations on the
negatively charged groups of the lipid and protein which interfere with the
reconstitution by electrostatic repulsion. This view was supported by recom-
bination of a phospholipid mixture and the protein moiety of thromboplastin
at pH 7.5 in the presence of cations with low and high affinities for lipicl sur-
faces (Na' and Mg2*) [12].
The elimination of the electrostatic repulsion by the added salt could also
be achieved by lowering the pH. The subsequent solubility problem of deoxy-
cholic acid could be surmounted by using taurocholate. By this modification.
we showed that maximum restoration of the thromboplastin activity is ob-
tained if the pH of the dialysis buffer is 4.0. The activity of the recombinant at
pH 4.0 was always higher than for recombinants prepared at pH T.b in the
presence of optimum concentration of sodium chloride (0.9b M) or manganese
chlor ide (0.01 M).
substitution of the thromboplastin phospholipid mixture by phosphatidic
acid, phosphatidylcholine, phosphatidylglycerol and phosphatidylserine
resulted in inactive recombinants, while some activity was found in the phos-
phatidylethanolamine recombinant. The observations with phosphatidylcholine
and phosphatidylethanolamine are not identical with those of the majority of
the previous studies [5,7,8]. This contradiction can be due to the use of
impure phospholipid preparations because of the previous lack of convenient
purification methods or unnoticed degradation of the lipids during storage. An
increased negative charge of the phosphatidylcholine and phosphatidylethanol-
amine micelles is a usual consequence due to the presence of the cleaved, nega-
tively charged fatty acids in the micelles.
Investigations with mixtures of phospholipids revealed that the charge of
the lipid moiety is very critical in the restoration of the procoagulant property
of the protein moiety. The negative charge of pure phospholipids is too low
(phosphatidylethanolamine and phosphatidyrcholine) (Fig. 1) or too high
(phosphatidylserine, phosphatidic acid and phosphatidylglycerol) (Fig. 1) (1t),
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butthechargeofpart icularmixturesteaches.thecorrectvalue.Lipidmixtures
whose miceres tuu"*ur, "i"ctrophoreti" 
*.til itv of -?.05'10-4 cmt 
's-t 'v-'
in 0.01b M veronal/;l;;il;il;ffer, 
pH ?.8b, produced the.most active recom-
binants (Fig. 1). rr,"l*p"rtance-of trr" 
r"rrut" charge could be illustrated with
mixtures of phosphatidylglyceroi, u rufuiJ"i' 
minorlipid component in animal
tissues, and the nonphysiologigal. ,t"uroyiurnine. 
The mixture phosphatidylgly-
cerol/stearovru*irr"''siiii i*l*l which 
had the above mobility restored the
activity of the prot"irr. The function 
-ol- 
iiri, parbicular charge of the lipid
moiety may be ".""""tJ 
with the Uirraittg oi calcium which 
could' in its
tum. be critical lrr'it"-tor*ation of 
ttre ttrromuoplastin'calcium'factor 
VII
"ttfrl?T'*udies dearing with a relation between the 
charge of lipids and their
clotting activitv *"1"^i"'to'mea u1!3"+"* f 
ZSl y9'tio*adjopoulos et al'
1241. Inthese stud'ili ^" "** 
.f tn"'"ft*g" oi tipiat was observed in 
the
stypven time test* iigi u"a il Lh"'u"iir"tio" 
of prothrombin [24]' our
investigations on ,t "' "-upu"ity 
of the t"""*ui"u"ts to act in 
prothrombinase
formation are related to the same step 
i" trr" clotting mechanism and they 
con-
iirm ttre Previous results'
Investigatior* i"To l-t " 
separation of tissue thromboplastin 
preparations into
their lipid urra prJ"ir, fractions strowea 
lrre existence of hvdrophobic interac-
tions between uotr, moieties. rattv 
Ji;il of the lipids are involved 
in
this type of interactio.r. ct u"ges in 
ttre degree of saturation of these 
chains
markedry i'n,r"rr"ll-Tr," u"tiuit"v .f th;;;-;;inant 
(Fig' 2)' Lipids containing
only saturatea tat'ti 
";|'f,; 
;ft"""d;;;;i;i"rv i"u"tive 
recombinants' rhis
demonstrates that, besides the charge 
;;;i-trlipft, the physicochemical condi-
tion of the hydroiffiil; snodi 
*u"tl 
""ttuin 
conditions which are impor-
tantfortheact iv i tyofthe,""o*r i , ,u, , t . Inthisrespect, thelowerr igidi tyof
the unsaturatea taitrr acid chains "1!; 
iipia, trt" 
"r"^t91 
location of methyl
groups of these t;l; ""id "hains 
to. th;;;il;egion of the membrane 
and the
greater 
"ro*r-.""r--i"ul-ur"u 
of trr" ptr.rpri.Gas Lay be important 
points with
relation.to cenarn requiied interactio-f, 
of tfte hydiophobic moieties between
the liPid and the Protein'
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